92 related articles for article (PubMed ID: 14571699)
1. Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.
Hirata K; Takada M; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2003; 50(53):1205-7. PubMed ID: 14571699
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of RAGE in human pancreatic carcinoma cells.
Takada M; Koizumi T; Toyama H; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2001; 48(42):1577-8. PubMed ID: 11813576
[TBL] [Abstract][Full Text] [Related]
3. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.
Takada M; Hirata K; Ajiki T; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2004; 51(58):928-30. PubMed ID: 15239215
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
5. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
Chou DK; Zhang J; Smith FI; McCaffery P; Jungalwala FB
J Neurochem; 2004 Sep; 90(6):1389-401. PubMed ID: 15341523
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.
Kuniyasu H; Chihara Y; Takahashi T
Oncol Rep; 2003; 10(2):445-8. PubMed ID: 12579287
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of tea polyphenol and conformational changes with receptor for advanced glycation end products (RAGE) expression in human hepatoma cells.
Takada M; Ku Y; Toyama H; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2002; 49(46):928-31. PubMed ID: 12143244
[TBL] [Abstract][Full Text] [Related]
8. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
Kuniyasu H; Oue N; Wakikawa A; Shigeishi H; Matsutani N; Kuraoka K; Ito R; Yokozaki H; Yasui W
J Pathol; 2002 Feb; 196(2):163-70. PubMed ID: 11793367
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.
Huttunen HJ; Fages C; Kuja-Panula J; Ridley AJ; Rauvala H
Cancer Res; 2002 Aug; 62(16):4805-11. PubMed ID: 12183440
[TBL] [Abstract][Full Text] [Related]
11. Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.
Sasahira T; Kirita T; Bhawal UK; Yamamoto K; Ohmori H; Fujii K; Kuniyasu H
Histopathology; 2007 Aug; 51(2):166-72. PubMed ID: 17593216
[TBL] [Abstract][Full Text] [Related]
12. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.
Bartling B; Hofmann HS; Weigle B; Silber RE; Simm A
Carcinogenesis; 2005 Feb; 26(2):293-301. PubMed ID: 15539404
[TBL] [Abstract][Full Text] [Related]
14. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
15. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y
Oncology; 2005; 69(3):246-55. PubMed ID: 16127291
[TBL] [Abstract][Full Text] [Related]
16. Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma.
Schraml P; Bendik I; Ludwig CU
Cancer Res; 1997 Sep; 57(17):3669-71. PubMed ID: 9288769
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.
Wang L; Li S; Jungalwala FB
J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
19. Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE.
Nakano N; Fukuhara-Takaki K; Jono T; Nakajou K; Eto N; Horiuchi S; Takeya M; Nagai R
J Biochem; 2006 May; 139(5):821-9. PubMed ID: 16751589
[TBL] [Abstract][Full Text] [Related]
20. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.
Taguchi A; Blood DC; del Toro G; Canet A; Lee DC; Qu W; Tanji N; Lu Y; Lalla E; Fu C; Hofmann MA; Kislinger T; Ingram M; Lu A; Tanaka H; Hori O; Ogawa S; Stern DM; Schmidt AM
Nature; 2000 May; 405(6784):354-60. PubMed ID: 10830965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]